Trial intelligence / Profile preview

Interferon beta-1a for maintenance of remission in Crohn's disease

NCT00304252Phase 2Terminated

Sponsor
EMD Serono
Start
Nov 2001
Modality
Cytokines & Interferons
Countries
5
01

Overview

A Phase 2 trial of interferon beta in Crohn's disease, sponsored by EMD Serono. Started Nov 2001; status: terminated.

02

Drugs

interferon beta
03

Conditions

Crohn's disease

Beyond the preview

Go deeper on NCT00304252.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00304252.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call